Association of BMI category change with TB treatment mortality in HIV-positive smear-negative and extrapulmonary TB patients in Myanmar and Zimbabwe

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Benova, Lenka ^a   Fielding, Katherine ^a   Greig, Jane ^b   Nyang'wa, Bern Thomas ^b   Casas, Esther Carrillo ^b   da Fonseca, Marcio Silveira ^b   du Cros, Philipp ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ETHAMBUTOL; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MYANMAR; RETROSPECTIVE STUDY; SMEAR; SPUTUM SMEAR; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MULTIVARIATE ANALYSIS; PATHOLOGY; TREATMENT OUTCOME; TUBERCULOSIS; ZIMBABWE;

ADULT; ANTITUBERCULAR AGENTS; BODY MASS INDEX; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MULTIVARIATE ANALYSIS; MYANMAR; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS; ZIMBABWE;

EID: 84860204461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035948     Document Type: Article

References (33)

1. World Health Organization (2011) Global Tuberculosis Control 2011 Geneva World Health Organization.
2. World Health Organization (2009) Global Tuberculosis Control: a short update to the 2009 report. Geneva World Health Organization.
3. Lawn S, Wood R, De Cock KM, Kranzer K, Lewis JJ, et al. (2010) Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infectious Disease 10: 489-498.
4. Lawn S, Badri M, Wood R, (2005) Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 19: 2109-2116.
5. Dimairo M, MacPherson P, Bandason T, Zezai A, Munyati S, et al. (2010) The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe. PLoS One 5: e11849.
6. Lawn S, Harries AD, Williams BG, Chaisson R, Losina E, et al. (2011) Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? International Journal of Tuberculosis & Lung Disease 15: 571-581.
7. Mukadi YD, Maher D, Harries A, (2001) Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 15: 143-152.
8. Nahid P, Jarlsberg L, Rudoy I, de Jong B, Unger A, et al. (2011) Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infectious diseases 11.
9. Glynn JR, Murray J, Shearer S, Sonnenberg P, (2010) Tuberculosis and survival of HIV-infected individuals by time since seroconversion. AIDS 24: 1067-1069.
10. Waitt C, Squire S, (2011) A systematic review of risk factors for death in adults during and after tuberculosis treatment. International Journal of Tuberculosis & Lung Disease 15: 871-885.
11. Dembelé M, Saleri N, Migliori G, Ouedraogo H, Carvalho A, et al. (2008) High incidence of sputum smear negative tuberculosis during HAART in Burkina Faso. Eur Respir J 32: 1668-1669.
12. Nicholas S, Balkan S, Pujades Rodrguez M, (2009) Outcomes of tuberculosis treatment in HIV-infected adults: multicentric analysis in 8 African HIV/AIDS programs. MSF Intersectional SPOT report. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa:http://www.ias2009.org/pag/Abstracts.aspx?AID=3092.
13. Lawn S, Myer L, Bekker L, Wood R, (2006) Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 20: 1605-1612.
14. Getahun H, Harrington M, O'Brien R, Nunn P, (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369: 2042-2049.
15. World Health Organization (2011) Zimbabwe Tuberculosis Country Profile. Geneva World Health Organization.
16. World Health Organization (2011) Myanmar Tuberculosis Country Profile. Geneva World Health Organization.
17. Nakanjako D, Mayanja-Kizza H, Ouma J, Wanyenze R, Mwesigire D, et al. (2010) Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. International Journal of Tuberculosis and Lung Disease 14: 1621-1628.
18. Maro I, Lahey T, MacKenzie T, Mtei L, Bakari M, et al. (2010) Low BMI and falling BMI predict HIV-associated tuberculosis: A prospective study in Tanzania. International Journal of Tuberculosis and Lung Disease 14: 1447-1453.
19. Semba RD, Darnton-Hill I, De Pee S, (2010) Addressing tuberculosis in the context of malnutrition and HIV coinfection. Food and Nutrition Bulletin 31: S345-S364.
20. Ahoua L, Umutoni C, Huerga H, Minetti A, Szumilin E, et al. (2011) Nutrition outcomes of HIV-infected malnourished adults treated with ready-to-use therapeutic food in sub-Saharan Africa: A longitudinal study. Journal of the International AIDS Society 14 doi:10.1186/1758-2652-1114-1182.
21. Hanrahan C, Golub J, Mohapi L, Tshabangu N, Modisenyane T, et al. (2010) Body mass index and risk of tuberculosis and death. AIDS 24: 1501-1508.
22. Mupere E, Zalwango S, Chiunda A, Okwera A, Mugerwa R, et al. (2010) Body Composition among HIV-seropositive and HIV-seronegative adult patients with pulmonary tuberculosis in Uganda. Annals of Epidemiology 20: 210-216.
23. Mossdorf E, Stoeckle M, Mwaigomole EG, Chiweka E, Kibatala PL, et al. (2011) Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition. BMC Infectious Diseases 11.
24. Bernabe-Ortiz A, Carcamo CP, Sanchez JF, Rios J, (2011) Weight variation over time and its association with tuberculosis treatment outcome: A longitudinal analysis. PLoS One 6: e18474.
25. Khan A, Sterling T, Reves R, Vernon A, Horsburgh C, et al. (2006) Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial American Journal of Respiratory and Critical Care Medicine 174: 344-348.
26. World Health Organization (2010) Treatment of tuberculosis: guidelines - 4th ed Geneva World Health Organization.
27. Krapp F, Veliz J, Cornejo E, Gotuzzo E, Seas C, (2008) Bodyweight gain to predict treatment outcome in patients with pulmonary tuberculosis in Peru. International Journal of Tuberculosis & Lung Disease 12: 1153-1159.
28. World Health Organization (2006) Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: Recommendations for HIV-prevalent and resource-constrained settings Geneva World Health Organization.
29. Kruyt M, et al. (1999) True status of smear-negative pulmonary tuberculosis defaulters in Malawi. Bull World Health Organ 77: 386-391.
30. Maher D, (2005) Tuberculosis deaths among populations with high HIV prevalence Geneva World Health Organization.
31. Kang'ombe C, Harries AD, Banda H, Nyangulu DS, Whitty CJ, et al. (2000) High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up. Transactions of the Royal Society of Tropical Medicine & Hygiene 94: 305-309.
32. Mukherjee A, Singla R, Saha I, (2009) Comparing outcomes in new pulmonary sputum positive and sputum negative cases under RNTCP in rural India. Indian J Tuberc 56: 144-150.
33. Ramos J, Reyes F, Tesfamariam A, (2010) Childhood and adult tuberculosis in a rural hospital in Southeast Ethiopia: a ten-year retrospective study. BMC Public Health 10.